Physician profile
Gerald Skipper
NPI 1275507170
$5,614.78
in general payments reported to CMS, 2019-2025
32 companies · $826 in 2025
The $826 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $915 · 2020: $839 · 2021: $700 · 2022: $566 · 2023: $771 · 2024: $998 · 2025: $826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,594.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $857.57 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $701.96 | 2020-2025 | Jardiance, Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $669.92 | 2019-2025 | Ofev, Jascayd, Jardiance |
| Novo Nordisk INC | $497.86 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $385.50 | 2019-2025 | Repatha, Otezla, Evenity |
| Dexcom, INC. | $331.42 | 2021-2025 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $323.65 | 2019-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $243.52 | 2019-2023 | Gardasil 9 |
| Takeda Pharmaceuticals U.S.A., INC. | $242.06 | 2019-2022 | |
| Glaxosmithkline, LLC. | $200.44 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $189.43 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $162.22 | 2021-2025 | |
| Abbvie INC. | $129.30 | 2021-2025 | |
| Kowa Pharmaceuticals America, INC. | $103.76 | 2019-2025 | Zoryve |
| Sanofi-Aventis U.S. LLC | $77.23 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $71.48 | 2023-2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $56.41 | 2019 | |
| Philips North America LLC | $52.29 | 2024-2025 | (Cm9) Amb Mon & Diag Und, Ambulatory Monitoring & Diagnostics Undivided |
| Astellas Pharma US INC | $50.61 | 2024 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.93 | 2024-2025 | Xifaxan |
| Melinta Therapeutics, LLC | $43.00 | 2019 | |
| Shire North American Group INC | $29.44 | 2019 | |
| Corcept Therapeutics | $20.83 | 2022 | |
| Xeris Pharmaceuticals, INC. | $16.88 | 2023 | Gvoke Hypopen |
| Regeneron Healthcare Solutions, INC. | $15.68 | 2024 | Evkeeza |
| Nestle Healthcare Nutrition INC. | $15.62 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.57 | 2022 | |
| Ironshore Pharmaceuticals INC. | $14.56 | 2019 | |
| Vivus LLC | $13.76 | 2021 | |
| Sanofi Pasteur INC. | $13.63 | 2021 | |
| Corium, LLC | $12.16 | 2022 | |
| Avanir Pharmaceuticals, INC. | $11.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Skipper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.